영국 - 영어 - MHRA (Medicines & Healthcare Products Regulatory Agency)

alliance healthcare (distribution) ltd - diethylstilbestrol - oral tablet - 5mg

몰타 - 영어 - Medicines Authority

p & d pharmaceuticals limited 38 woolmer way, bordon hampshire gu35 9qf, united kingdom - diethylstilbestrol - film-coated tablet - diethylstilbestrol 5 mg - endocrine therapy

몰타 - 영어 - Medicines Authority

p & d pharmaceuticals limited - diethylstilbestrol - tablet - diethylstilbestrol 1 mg - endocrine therapy

몰타 - 영어 - Medicines Authority

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - diethylstilbestrol - film-coated tablet - diethylstilbestrol 5 mg - endocrine therapy

오스트레일리아 - 영어 - APVMA (Australian Pesticides and Veterinary Medicines Authority)

david gray & co. pty limited - diethyltoluamide - unknown - diethyltoluamide insect repellent active 0.0 - active constituent

오스트레일리아 - 영어 - APVMA (Australian Pesticides and Veterinary Medicines Authority)

virbac (australia) pty ltd - diethyltoluamide - unknown - diethyltoluamide insect repellent active 0.0 - active constituent

미국 - 영어 - NLM (National Library of Medicine)

qualitest products, inc. - diethylpropion hydrochloride (unii: 19v2pl39ng) (diethylpropion - unii:q94yyu22b8) - tablet, extended release - 75 mg - diethylpropion hydrochloride tablets are indicated in the management of exogenous obesity as a short-term adjunct (a few weeks) in a regiment of weight reduction based on caloric restriction. the usefulness of agents of this class should be measured against possible risk factors inherent in their use such as those described (see clinical pharmacology). diethylpropion hydrochloride should not be used in patients with advanced arteriosclerosis, hyperthyroidism, known hypersensitivity or idiosyncrasy to the sympathomimetic amines, glaucoma, severe hypertension, a history of drug abuse, or those in an agitated state (see precautions). diethylpropion hydrochloride should not be given during, or within fourteen days following, the administration of monoamine oxidase inhibitors; hypertensive crises may result. diethylpropion is a schedule iv controlled substance. diethylpropion has some chemical and pharmacologic similarities to the amphetamines and other related stimulant drugs that have been extensively abused.

미국 - 영어 - NLM (National Library of Medicine)

rebel distributors corp - diethylpropion hydrochloride (unii: 19v2pl39ng) (diethylpropion - unii:q94yyu22b8) - diethylpropion hydrochloride is indicated in the management of exogenous obesity as a short-term adjunct (a few weeks) in a regimen of weight reduction based on caloric restriction in patients with an initial body mass index (bmi) of 30 kg/m2 or higher and who have not responded to appropriate weight reducing regimen (diet and/or exercise) alone. below is a chart of bmi based on various heights and weights. bmi is calculated by taking the patient’s weight, in kilograms (kg), divided by the patient’s height, in meters (m), squared. metric conversions are as follows: pounds divided by 2.2 = kg; inches x 0.0254 = meters. the usefulness of agents of this class (see clinical pharmacology ) should be measured against possible risk factors inherent in their use such as those described below. diethylpropion hydrochloride is indicated for use as monotherapy only. pulmonary hypertension, advanced arteriosclerosis, hyperthyroidism, known hypersensitivity or idiosyncrasy to the sympathomimetic amines, glaucoma, severe h

미국 - 영어 - NLM (National Library of Medicine)

unit dose services - diethylpropion hydrochloride (unii: 19v2pl39ng) (diethylpropion - unii:q94yyu22b8) - diethylpropion hydrochloride is indicated in the management of exogenous obesity as a short-term adjunct (a few weeks) in a regimen of weight reduction based on caloric restriction in patients with an initial body mass index (bmi) of 30 kg/m or higher and who have not responded to appropriate weight reducing regimen (diet and/or exercise) alone. below is a chart of bmi based on various heights and weights. bmi is calculated by taking the patient’s weight, in kilograms (kg), divided by the patient’s height, in meters (m), squared. metric conversions are as follows: pounds divided by 2.2 = kg; inches x 0.0254 = meters. 2 the usefulness of agents of this class (see ) should be measured against possible risk factors inherent in their use such as those described below. diethylpropion hydrochloride is indicated for use as monotherapy only. clinical pharmacology pulmonary hypertension, advanced arteriosclerosis, hyperthyroidism, known hypersensitivity or idiosy

미국 - 영어 - NLM (National Library of Medicine)

blenheim pharmacal, inc. - diethylpropion hydrochloride (unii: 19v2pl39ng) (diethylpropion - unii:q94yyu22b8) - diethylpropion hydrochloride is indicated in the management of exogenous obesity as a short-term adjunct (a few weeks) in a regimen of weight reduction based on caloric restriction in patients with an initial body mass index (bmi) of 30 kg/m 2 or higher and who have not responded to appropriate weight reducing regimen (diet and/or exercise) alone. below is a chart of bmi based on various heights and weights. bmi is calculated by taking the patient’s weight, in kilograms (kg), divided by the patient’s height, in meters (m), squared. metric conversions are as follows: pounds divided by 2.2 = kg; inches x 0.0254 = meters. the usefulness of agents of this class (see clinical pharmacology ) should be measured against possible risk factors inherent in their use such as those described below. diethylpropion hydrochloride is indicated for use as monotherapy only. pulmonary hypertension, advanced arteriosclerosis, hyperthyroidism, known hypersensitivity or idiosyncrasy to the sympathomimetic